Cell And Gene Therapy Videos

  1. Building A Path To A Successful AAV Product 1/26/2026

    See state‑of‑the‑art analytical methods for AAV characterization, key quality attributes to monitor, and approaches for measuring infectivity and full‑to‑empty capsid ratios.

  2. Detecting Particles In Biologic And CGT Drug Products 1/26/2026

    Identify and characterize visible and subvisible particles that can form during biologic and cell or gene therapy development.

  3. AUC As An Alternative For Biologics, Gene Therapy Characterization 1/26/2026

    Learn how Analytical Ultracentrifugation enables detailed characterization of biologics, vaccines, and gene therapy vectors, offering a powerful alternative for R&D and emerging QC needs.

  4. Choosing The Right CDMO Partner In Biopharma 1/15/2026

    Selecting a CDMO is a high-stakes strategic decision impacting quality, timelines, and regulatory success. The right partner offers integrated capabilities, scientific expertise, agility, transparency, innovation, and shared purpose.

  5. How In-House CDMO Analytics Reduce Risk and Cost 1/15/2026

    Explore why integrated analytics within CDMOs is transforming biopharma: reducing risk, speeding timelines, ensuring data integrity, and preventing costly failures through seamless manufacturing and testing collaboration.

  6. Audiopost: From Research Stage To GMP Production 1/15/2026

    Discover the critical shift from flexible research to rigid GMP manufacturing, shaped by historic tragedies, strict regulations, and uncompromising standards—all to ensure medicine safety and patient trust.

  7. Cytiva's Aseptic Filling Workcell User Group 1/9/2026

    Discover how global collaboration among aseptic filling experts is driving innovation and improving operations.

  8. Hear From The Experts: LNPs Driving The Future Of Cell Therapy 12/12/2025

    Explore how lipid nanoparticles are driving breakthroughs in cell therapy, from mRNA-based immune cell engineering to genome editing for CAR T cells and HSPCs from leading experts.

  9. Eliminate Risk From Your Viral Vector Tech Transfers 12/5/2025

    Explore strategies to simplify viral vector tech transfers, reduce risk, and maintain quality under tight timelines, as well as a case study that demonstrates how to streamline this critical process.

  10. Model-Driven Genetic Design And Bioprocess Optimization Across Modalities 12/2/2025

    Traditional biomanufacturing relies too heavily on trial and error. By integrating AI and mechanistic models into early design, developers can overcome productivity limits and accelerate timelines.